Filing Flows › Prokidney (PROK) › Q1 2026
Prokidney (PROK) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Prokidney (PROK) reported revenue of $226K for the first quarter 2026 (Q1 2026), -2% from a year earlier and +0.4% from the quarter before.
Prokidney, Q1 2026: revenue $226K (-2% year over year), net loss $42.6M, operating cash flow −$41.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $226K | +0.4% | -2% |
| Operating profit | −$44.9M | — | — |
| Net earnings | −$42.6M | — | — |
| Operating cash flow | −$41.7M | — | — |
What changed
Revenue was $226K in Q1 2026, down 2% year over year and roughly flat from the previous quarter.
Operating costs exceeded revenue by $44.9M, an operating margin of -19881.9%. Total costs grew 9% against a revenue fall of 2%. The fastest-growing cost line was Research & development (+24%). The quarter ended with a net loss of $42.6M, wider than the previous quarter's $40.9M loss. Minority interests bore $22.6M of it: to shareholders the quarter was a loss of $20.0M.
Operating cash flow was −$41.7M. Non-cash charges added back $1.7M of depreciation and amortization and $4.9M of share-based compensation. Working capital and other items used $5.7M. Capital expenditures of $3.8M exceeded it, leaving free cash flow of −$45.5M.
Questions
What was Prokidney's revenue in the first quarter 2026?
Prokidney (PROK) reported revenue of $226K for the first quarter 2026 (Q1 2026), -2% from a year earlier and +0.4% from the quarter before.
Source: Prokidney 10-Q on SEC EDGAR.